ascopubs.org15d
Efficacy and safety of lenvatinib plus everolimus in metastatic renal cell carcinoma after immune checkpoint and VEGFR tyrosine kinase inhibitors.
Real world evidence from a retrospective multi-center analysis on first-line therapy for metastatic renal cell carcinoma with chromophobe histology.
Nasdaq1mon
Sandoz Group Appoints Peter Stenico As President Region Intl
(RTTNews) - Swiss generic pharmaceutical company Sandoz Group AG (SDZNY) announced on Monday that Peter Stenico has been appointed as the new President Region International and member of the ...
Frontiers1y
Population pharmacokinetics of everolimus in patients with seizures associated with focal cortical dysplasia
Background: Everolimus is an inhibitor of mammalian target of rapamycin complex 1. As mutations in TSC1 and TSC2, which cause partial-onset seizures associated with TSC, were found in focal cortical ...